Agendia is a leading molecular diagnostics company specializing in oncology, dedicated to providing innovative solutions that enhance cancer treatment and patient outcomes. With a focus on precision medicine, Agendia develops advanced genomic tests, such as MammaPrint and BluePrint, that empower healthcare professionals to make informed decisions in cancer care. The company is committed to ethical marketing practices and fostering strong relationships with healthcare providers, ensuring that their products meet the highest standards of quality and compliance. Agendia operates with a collaborative approach, engaging with various departments and stakeholders to drive sales and support the oncology community.